HOME: Home Monitoring of High-risk Pregnancies
The HOME Study: Home Monitoring of High-risk Pregnancies
1 other identifier
observational
250
1 country
1
Brief Summary
High-risk pregnancies often require long-term hospitalization or outpatient maternal and/or fetal monitoring, placing a burden on patients, hospital resources and society. The demand for intensified pregnancy surveillance and interventions is increasing, due to the increased prevalence of risk factors like obesity and advanced maternal age, as well as altered guidelines resulting in increasing labor induction rates.The main aims of the HOME study (Home monitoring of pregnancies at risk) are to assess if home monitoring of selected high-risk pregnancies for maternal and fetal wellbeing is feasible, safe (in a clinical trial), cost-efficient, and simultaneously empowers the users.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 21, 2022
CompletedFirst Submitted
Initial submission to the registry
February 28, 2023
CompletedFirst Posted
Study publicly available on registry
March 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2035
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2040
February 18, 2026
February 1, 2026
12.8 years
February 28, 2023
February 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of Home monitoring of high-risk pregnancies
Development of secure data transfer systems from home to electronic patient records at the hospital
2022-2035
Secondary Outcomes (4)
User acceptability of home monitoring
2022-2035
Clinical safety of home monitoring
2022-2035
Health economics of home monitoring
2022-2035
Placenta-associated biomarkers: improving CTG prediction of adverse outcomes?
2023-2035
Interventions
Offer women with pregnancies at risk home surveillance instaed of more frequent hospital out-patient visits and/or hospitalisation: cardiotocographia (CTG), patient measurements of CRP, temperature, blood pressure, and clinical signs of infection or severe forms of preeclampsia.
Eligibility Criteria
Pregnant women identified with the at-risk pregnancies described above, attending Oslo University Hospital's Department of Obstetrics (some controls will also be recruited at another South-Eastern Norway Dept of Obstetrics, at Drammen hospital).
You may qualify if:
- Preeclampsia
- Gestational Hypertension
- Premature Preterm Rupture of Membranes
- High Risk Pregnancy
- Previous adverse obstetric outcomes
You may not qualify if:
- Multiples (twins, triplets etc)
- Patient or fetus in immediate need for delivery
- Not understanding Norwegian
- Not mastering the technological aspects of home monitoring
- Long travel distance to Obstetric Department
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oxfordcollaborator
- Rigshospitalet, Denmarkcollaborator
- Digniocollaborator
- Medexacollaborator
- Oslo University Hospitallead
- University of Oslocollaborator
- Norwegian SIDS and Stillbirth Societycollaborator
- Sykehuspartnercollaborator
Study Sites (1)
Oslo University Hospital
Oslo, 0424, Norway
Related Publications (1)
Waldum AH, Pay ASD, Aasbo G, Mishra VK, Sugulle M, Staff AC. The HOME (home monitoring of high-risk pregnancies) study: a study protocol for an observational study of a telemedicine-assisted follow-up at home vs. hospitalization. Front Glob Womens Health. 2025 Jul 14;6:1599153. doi: 10.3389/fgwh.2025.1599153. eCollection 2025.
PMID: 40726590DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Cathrine Staff, MD, PhD
Oslo University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Head of research, MD; PhD
Study Record Dates
First Submitted
February 28, 2023
First Posted
March 10, 2023
Study Start
November 21, 2022
Primary Completion (Estimated)
September 1, 2035
Study Completion (Estimated)
September 1, 2040
Last Updated
February 18, 2026
Record last verified: 2026-02